We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Early Markers Detected For Epstein Barr Virus

By LabMedica International staff writers
Posted on 03 Dec 2012
Molecular tests that can identify early protein markers produced by Epstein Barr Virus (EBV) may have value for diagnosing active infection.

The benefits of this diagnostic approach in patients with mononucleosis and in EBV-infected transplant patients have been evaluated by comparing three different immunoassays.

Scientists at University College Dublin (Ireland) investigate the diagnostic value of anti-early antigen (EA) immunoglobulin G (IgG) testing in the stage-specific differential diagnosis of EBV infection in immunocompetent individuals with atypical antibody responses. More...
Furthermore, they assessed whether anti-EA IgG detection in conjunction with EBV DNA viral load quantification had better predictive value than EBV DNA alone in the diagnosis of EBV-associated disease in immunosuppressed adult liver transplant recipients. During the study period, none of the patients developed post-transplantation lymphoproliferative disorders (PTLD).

Eighty-five serum or plasma samples from 69 individuals were selected from the archived database. The detection of EA IgG in patients' samples was carried out using three different specific serological assays. The enzyme-linked immunosorbent assay (ELISA) is a microtiter plate assay, which detects and quantifies specific human IgG against EBV p54 EA. The Liaison chemiluminescent immunoassay (CLIA) is a two-step, immunoluminometric sandwich assay using directly coated magnetic particles for the detection of EBV EA IgG against the p54 EA. The recomBlot EBV IgG qualitative immunoblot assay was used as the gold standard. Amplification and quantification of DNA was performed using the Light Cycler EBV Quantification kit (Roche Diagnostics; Mannheim, Germany).

The results showed that the CLIA (DiaSorin; Saluggi, Italy) and immunoblot (Mikrogen; Neuried, Germany) produced more comparable results. However, there was a significant difference between the results of the ELISA (MP Biomedicals; Eschwege, Germany) and the immunoblot EA IgG assays and the results of the CLIA and ELISA assays. Comparisons with the immunoblot results showed that the CLIA is more sensitive (77%) than the ELISA (50%), but that the CLIA is less specific (42%) than the ELISA (100%).

The authors concluded that the automated CLIA was found to be more accurate than the ELISA when using the immunoblot assay as a “gold standard” assay in the detection of EA IgG. There may be a potential role for EA IgG testing, together with EBV viral load, in the prediction of transplant recipients at risk of EBV-associated disease. However, EA IgG does not play a significant role in the differential diagnosis of EBV infection in immunocompetent individuals. The study was published on November 2, 2012, in the journal BioResearch Open Access.

Related Links:

University College Dublin
Roche Diagnostics
DiaSorin



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Nucleic Acid Purification Instrument
QIAsymphony Connect
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.